Cognitive Behavioral Therapy for Depression in Parkinson's Disease

This study is enrolling participants by invitation only.
Sponsor:
Collaborator:
National Parkinson Foundation
Information provided by:
Oregon Health and Science University
ClinicalTrials.gov Identifier:
NCT00810628
First received: December 17, 2008
Last updated: NA
Last verified: December 2008
History: No changes posted
  Purpose

The purpose of this pilot program is to develop and evaluate a new treatment program for depression in Parkinson's disease (PD). The treatment uses Cognitive Behavior Therapy(CBT)to teach patients how to become more aware of their thoughts and feelings and to change thinking patterns and behaviors that may be related to depressive symptoms. This is the first time that this treatment has been used in a group setting for depression in PD.

Target population is patients in the Movement Disorders Clinic at Oregon Health & Science University who have Parkinson's disease and mild to moderate depression.


Condition Intervention
Parkinson's Disease
Depression
Behavioral: Cognitive Behavioral Therapy

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: Depression in Parkinson's Disease: A Pilot Project Using Cognitive Behavioral Therapy (CBT) to Improve Depression and Coping

Resource links provided by NLM:


Further study details as provided by Oregon Health and Science University:

Primary Outcome Measures:
  • To be developed, including change in CESD score [ Time Frame: 10 weeks ] [ Designated as safety issue: No ]

Estimated Enrollment: 12
Study Start Date: January 2009
Estimated Study Completion Date: December 2009
Estimated Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
All subjects in same investigative group with same CBT intervention.
Behavioral: Cognitive Behavioral Therapy
Individual interviews and group discussion/training.

  Eligibility

Ages Eligible for Study:   35 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Parkinson's disease, mild to moderate depression, seen at Oregon Health & Science University

Exclusion Criteria:

  • Suicidal
  • Cognitive impairment with MOCA <26
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00810628

Locations
United States, Oregon
Oregon Health & Science University
Portland, Oregon, United States, 97239
Sponsors and Collaborators
Oregon Health and Science University
National Parkinson Foundation
Investigators
Principal Investigator: Julie H. Carter, MS Oregon Health and Science University
Principal Investigator: Kristine Hanna, PhD Oregon Health and Science University
  More Information

Publications:
Responsible Party: Julie Carter, MS, ANP, Oregon Health & Science University
ClinicalTrials.gov Identifier: NCT00810628     History of Changes
Other Study ID Numbers: OHSUIRB4613
Study First Received: December 17, 2008
Last Updated: December 17, 2008
Health Authority: United States: Institutional Review Board

Keywords provided by Oregon Health and Science University:
Parkinson's disease
depression
Parkinson's disease with mild to moderate depression.

Additional relevant MeSH terms:
Depression
Depressive Disorder
Parkinson Disease
Behavioral Symptoms
Mood Disorders
Mental Disorders
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases

ClinicalTrials.gov processed this record on August 01, 2014